Goldline Pharmaceutical Peer Comparison

BSE: 544759

₹33.15

₹-0.16 (-0.48%)

As on 22-Sep-2026IST

Market cap

₹32 Cr

Revenue (TTM)

₹31 Cr

P/E Ratio

7.7

P/B Ratio

1.3

Div. Yield

0 %

Edit

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Market cap (₹ Cr)	32	8,007	32	28	28
Revenue (₹ Cr)	31	7,128	13	71	366
Net Profit (₹ Cr)	4.12	167.66	-1.78	5.98	-16.99
Net Margin (%)	13.20	2.35	-8.71	8.44	-4.63
RoE (%)	39.41	7.58	-1.56	21.69	-14.35
Price to Earnings	7.73	63.85	--	4.63	--
Price-To-Book	1.32	4.62	0.29	0.73	0.29

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Operating Revenue	31.20	6,591.21	12.45	70.83	--
Total Income	31.20	6,610.45	20.66	70.85	--
Total Expenditure	24.12	6,325.26	21.85	62.57	--
EBITDA	7.08	265.96	-9.40	8.26	--
Depreciation	0.24	43.29	1.81	0.03	--
EBIT	6.84	222.66	-11.21	8.23	--
Interest	1.46	54.39	0.02	0.26	--
Other Income	0.00	19.24	8.21	0.02	--
Exceptional Items	--	-8.18	--	--	--
Profit before Tax	5.39	179.34	-3.02	8.00	--
Provision for Tax	1.27	33.50	0.01	2.01	--
Profit after Tax	4.12	145.84	-3.04	5.98	--

Liabilities (₹ Cr)

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Shareholder's Funds	14.25	1,688.61	111.61	37.82	--
Minority Interest	--	63.94	--	--	--
Non-Current Liabilities	2.43	206.12	1.14	0.02	--
Current Liabilities	12.11	1,587.57	2.71	12.45	--
Total Liabilities	28.87	3,600.22	115.46	50.30	--

Assets (₹ Cr)

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Non-Current Assets	2.75	1,037.80	68.44	0.13	--
Current Assets	26.05	2,503.13	47.02	50.16	--
Total Assets	28.87	3,600.22	115.46	50.30	--
Total Debt*	9.16	566.68	0.00	5.18	--
Net Current Assets	13.93	915.56	44.31	37.71	--
Contingent Liabilities	3.37	5.51	--	--	--

Cashflow (₹ Cr)

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Cash From Operating Activities	2.81	96.20	-7.02	-19.48	--
Cash Flow from Investing Activities	-0.06	-303.06	7.11	-0.01	--
Cash from Financing Activities	-3.40	123.66	--	18.79	--
Net Cash Inflow / Outflow	-0.65	-83.20	0.09	-0.70	--

Ratios

Profitability Ratios

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
ROCE (%)	30.60	10.93	-2.58	27.06	--
ROE (%)	39.41	8.57	-2.61	21.69	--
ROA (%)	14.98	4.68	-2.52	16.33	--
EBIT Margin (%)	22.70	4.33	-9.59	11.69	--
Net Margin (%)	13.20	2.21	-14.70	8.44	--
Cash Profit Margin (%)	13.97	2.87	-9.88	8.48	--

Growth Ratios

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Revenue Growth (%)	11.20	29.35	-51.14	42.65	--
EBIT Growth (%)	16.95	35.13	-229.03	47.48	--
Net Profit Growth (%)	45.26	35.75	-431.96	44.38	--
EPS Growth (%)	45.26	21.32	-431.95	6.34	--
Book Value Growth (%)	47.19	-2.19	-7.97	117.98	--

Valuation Ratios

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Price / Earnings	0.00	47.12	0.00	3.92	--
Price / Book Value	0.00	3.22	0.26	0.62	--
Dividend Yield (%)	--	0.00	0.00	0.00	--
EV/EBITDA	2.44	20.43	-23.82	3.38	--
Market Cap (₹ Cr)	0.00	5,420.61	28.93	23.45	--

Solvency Ratios

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Debt to Equity	0.64	0.34	0.00	0.14	--
Short term debt to equity ratio	0.42	0.26	--	0.14	--
Current Ratio	2.15	1.58	17.34	4.03	--
Quick Ratio	1.64	1.05	16.26	3.53	--
Interest Coverage	4.70	4.30	-137.05	31.94	--

Operating Efficiency Ratios

	Goldline Pharmaceutical	Entero Health	Medi-Caps	Medistep Healthcare	Welcure Drugs
Debtors to sales (%)	51.70	18.39	55.60	55.61	--
Asset Turnover	1.13	2.11	0.10	1.93	--
Receivable days	156.90	56.56	230.34	153.31	--
Inventory Days	75.99	41.57	90.05	18.75	--
Payable days	64.86	34.66	71.74	18.03	--
Cash Conversion Cycle	168.03	63.47	248.65	154.03	--

Annual
Quarterly